Bosch–Boonstra–Schaaf optic atrophy syndrome
| Bosch–Boonstra–Schaaf optic atrophy syndrome | |
|---|---|
| Other names | BBSOAS[1] |
![]() | |
| This condition is inherited via autosomal dominant manner. | |
| Causes | mutations in the NR2F1 gene |
Bosch–Boonstra–Schaaf optic atrophy syndrome is a rare autosomally inherited condition characterised by developmental delay, intellectual disability and decreased visual acuity.[2][3][4]
Presentation
All patients described have suffered from developmental delay, intellectual disability (intelligence quotient range 48–74) and decreased visual acuity. Ocular abnormalities include small discs, pale discs, disc excavation, strabismus and latent nystagmus.
Other features of this condition are somewhat variable and include:
- Facial indicators
- Protruding ears
- Helical anomalies
- Small nasal ridge
- High nasal bridge
- Upturned nose
- Epicanthal folds
- Upslanting palpebral fissures
- Skeletal indicators
- Tapering fingers
- Hypotonia
Genetics
This condition is caused by mutations in the NR2F1 gene (formally named COUP-TF1). This gene is located on the long arm of chromosome 5 (5q15) and encodes a protein that acts as a nuclear receptor and transcriptional regulator. NR2F1 acts as a homo- or heterodimer and has two functionally conserved domains, a DNA building domain and a ligand binding domain.[5] The syndrome is inherited in an autosomal dominant fashion.[2] The variant spectrum is diverse and includes both missense variants and deletions.[6]
Genotype-phenotype correlation
The disease shows a clear genotype-phenotype correlation. Patients that have a loss of function variant (e.g. deletions) show a mild phenotype, while patients that carry a missense variant in the DNA binding domain show a severe neurological phenotype.[6]
Management
There is no curative treatment known at present for his condition. Management is supportive.[7]
Epidemiology
This condition is considered rare, with an estimated prevalence between 1 in 100,000 to 250,000 people worldwide.[6] So far BBSOAS has been diagnosed in more than 100 patients.[6]
History
This condition was first described in 2014.[2]
References
- ↑ "OMIM Entry – # 615722 – Bosch-Boonstra-Schaaf Optic Atrophy Syndrome; BBSOAS". omim.org. Retrieved 19 January 2020.
- 1 2 3 Bosch, Daniëlle G.M.; Boonstra, F. Nienke; Gonzaga-Jauregui, Claudia; Xu, Mafei; de Ligt, Joep; Jhangiani, Shalini; Wiszniewski, Wojciech; Muzny, Donna M.; Yntema, Helger G.; Pfundt, Rolph; Vissers, Lisenka E.L.M.; Spruijt, Liesbeth; Blokland, Ellen A.W.; Chen, Chun-An; Lewis, Richard A.; Tsai, Sophia Y.; Gibbs, Richard A.; Tsai, Ming-Jer; Lupski, James R.; Zoghbi, Huda Y.; Cremers, Frans P.M.; de Vries, Bert B.A.; Schaaf, Christian P. (2014). "NR2F1 Mutations Cause Optic Atrophy with Intellectual Disability". The American Journal of Human Genetics. 94 (2). Elsevier BV: 303–309. doi:10.1016/j.ajhg.2014.01.002. ISSN 0002-9297. PMC 3928641. PMID 24462372.
- ↑ Chen, Chun-An; Bosch, Daniëlle G.M.; Cho, Megan T.; Rosenfeld, Jill A.; Shinawi, Marwan; Lewis, Richard Alan; Mann, John; Jayakar, Parul; Payne, Katelyn; Walsh, Laurence; Moss, Timothy; Schreiber, Allison; Schoonveld, Cheri; Monaghan, Kristin G.; Elmslie, Frances; Douglas, Ganka; Boonstra, F. Nienke; Millan, Francisca; Cremers, Frans P.M.; McKnight, Dianalee; Richard, Gabriele; Juusola, Jane; Kendall, Fran; Ramsey, Keri; Anyane-Yeboa, Kwame; Malkin, Elfrida; Chung, Wendy K.; Niyazov, Dmitriy; Pascual, Juan M.; Walkiewicz, Magdalena; Veluchamy, Vivekanand; Li, Chumei; Hisama, Fuki M.; de Vries, Bert B.A.; Schaaf, Christian (2016). "The expanding clinical phenotype of Bosch-Boonstra-Schaaf optic atrophy syndrome: 20 new cases and possible genotype–phenotype correlations". Genetics in Medicine. 18 (11). Elsevier BV: 1143–1150. doi:10.1038/gim.2016.18. ISSN 1098-3600. PMID 26986877.
- ↑ Chen, Chun-An; Wang, Wei; Pedersen, Steen E; Raman, Ayush; Seymour, Michelle L; Ruiz, Fernanda R; Xia, Anping; van der Heijden, Meike E; Wang, Li; Yin, Jiani; Lopez, Joanna; Rech, Megan E; Lewis, Richard A; Wu, Samuel M; Liu, Zhandong; Pereira, Fred A; Pautler, Robia G; Zoghbi, Huda Y; Schaaf, Christian P (2020-03-27). "Nr2f1 heterozygous knockout mice recapitulate neurological phenotypes of Bosch-Boonstra-Schaaf optic atrophy syndrome and show impaired hippocampal synaptic plasticity". Human Molecular Genetics. 29 (5): 705–715. doi:10.1093/hmg/ddz233. ISSN 0964-6906. PMC 7104670. PMID 31600777.
- ↑ Tocco, Chiara; Bertacchi, Michele; Studer, Michèle (2021-12-15). "Structural and Functional Aspects of the Neurodevelopmental Gene NR2F1: From Animal Models to Human Pathology". Frontiers in Molecular Neuroscience. 14 767965. doi:10.3389/fnmol.2021.767965. ISSN 1662-5099. PMC 8715095. PMID 34975398.
- 1 2 3 4 Bertacchi, Michele; Tocco, Chiara; Schaaf, Christian P.; Studer, Michèle (2022-04-08). "Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome". Cells. 11 (8): 1260. doi:10.3390/cells11081260. ISSN 2073-4409. PMC 9024734. PMID 35455940.
- ↑ Schaaf, Christian P.; Yu-Wai-Man, Patrick; Valentin, Ilia (1993), Adam, Margaret P.; Bick, Sarah; Mirzaa, Ghayda M.; Pagon, Roberta A. (eds.), "NR2F1-Related Neurodevelopmental Disorder", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 36508512, retrieved 2026-06-21
